Departments

Yale Psychiatry is the largest provider of psychiatric services in Connecticut, and the top National Institutes of Health-supported Department of Psychiatry in the United States. We are dedicated to adding to the body of knowledge in the field, and improving treatments for psychiatric disorders that span all ages. This includes helping people cope with major life events or medical illnesses, behavioral problems associated with personality disorder or addiction, mood and psychotic disorders, and dementia. Yale investigators have pioneered new treatments for nearly every psychiatric disorder. Our research programs have produced breakthroughs in areas as diverse as molecular neuroscience, genetics, translational neuroscience, neuroimaging, psychopharmacology, psychotherapy, rehabilitation, health services, forensic psychiatry, epidemiology, and health policy. Today, our clinicians are at the forefront of social, pharmacological, psychological, rehabilitative, and neurostimulation treatments. Through clinical trials, our interventional psychiatry service delivers high-impact treatments, including ECT (electroconvulsive therapy) and ketamine, for patients with treatment-resistant symptoms of depression. Our clinical programs are interwoven with our research efforts. We host programs that specialize in the major mental diseases and substance abuse treatment at three major institutions: Connecticut Mental Health Center, the Veterans Affairs Connecticut Healthcare System, and the Yale New Haven Psychiatric Hospital. We also provide increased psychiatry support for Smilow Cancer Hospital in areas such as smoking cessation.

The Yale Child Study Center is an internationally recognized center of innovation in child and family mental health, dedicated to promoting healthy development and psychological well-being across the lifespan. We care for children and adolescents whose families are concerned about their child’s development and behavior. Common concerns include developmental delays, behaviors or worries that interfere with their child’s life, isolation and fear of school, and defiant and difficult behavior. Our first job is to listen. As we begin to understand the family and child, we will guide our patients through the evaluation, diagnosis, and treatment process. We provide office and home-based interventions as well as telehealth services, and we work with as many people involved in your child’s growth as possible, including parents, teachers and pediatricians. Above all, we care about your child’s development and your family’s well-being. We will use every means available—and maybe even invent some new ones—to help the child and their family. We are committed to working with every family to help them understand and address their child’s and family’s needs. Our interdisciplinary teams use up-to-date science to evaluate and then work with the family to develop a comprehensive treatment recommendations. Our treatment may include (one-on-one or group) therapy, family therapy, and parent-centered approaches and collaboration with schools. When appropriate, our providers will discuss the use of medication, providing detailed information so parents can make an informed decision. Many of our patients improve and thrive without medication, and for others it is a valuable part of their treatment. At the Yale Child Study Center, we are pioneering many treatments including approaches that help parents improve disruptive anger and aggression in children with autism and other developmental disorders. We are also developing new ways to help children overcome anxieties that may limit their daily lives, and treatment approaches designed to lessen the impact of an overwhelming event on the child and family. Finally, we work directly with parents around their own concerns about their roles as parents.

Yale Program in Addiction Medicine physicians and advanced practice providers prevent, diagnose, and treat substance use disorders and related harms. Our program, founded on over 30 years of pioneering research designed to integrate addiction treatment into general medical settings, is internationally recognized for leadership in the field and innovative approaches to care. Our clinicians are experienced in treating opioid, alcohol, tobacco, and other substance use disorders and in providing medications and behavioral therapy for substance use treatment. Our clinicians have training in a wide range of areas in medicine including internal medicine, primary care, emergency medicine, pediatrics, infectious diseases, psychiatry, pulmonary and critical care medicine. They are experienced in providing treatment for substance use alongside pregnancy and care for other co-occurring conditions such as pain, Hepatitis C, HIV, bacterial infections, and mental health diagnoses. Yale Program in Addiction Medicine clinicians see patients in community health centers, primary care clinics, infectious disease clinics, the emergency department, and in the hospital. We emphasize a patient-centered approach to care and will work with patients and their families to identify a treatment plan that best supports the patient’s needs and goals. Our clinicians meet patients where they are—whether they are new to treatment, returning to treatment, or exploring ways to reduce risk associated with substance use. Our dedicated clinicians are experienced in treating the full spectrum of substance use from intermittent use to severe substance use disorder. We use evidence-based treatment strategies to care for patients throughout the often relapsing-remitting nature of the disease of addiction and are supported by a large community of experts in the field working to develop and make available innovative, effective treatment options. In collaboration with our many community-based and institutional partners, we offer a robust network of care options to ensure appropriate support for our patients at every stage of treatment. Yale School of Medicine is a teaching institution. As such, patient care teams may include physician fellows, residents, advanced practice trainees, and or medical students being trained by our program in addiction medicine. The Yale Program in Addiction Medicine houses a robust research portfolio focused on advancing innovative treatments and improving the quality and efficacy of care for our patients. We are internationally recognized for our scholarly contributions to the field, particularly with respect to implementation and evaluation of medications for substance use treatment in primary care clinics, infectious disease clinics, the emergency department, and in the hospital, as well as comprehensive training and education of the next generation of addiction medicine providers. Our faculty and collaborators form an interdisciplinary team representing intern

Patients with moderate-to-severe psoriasis often require a host of medications to manage their disease. One type in particular—biologics—are highly effective, but they can be complicated to administer. They are also expensive, which means navigating insurance coverage can be difficult and result in treatment delays. The Psoriasis Treatment Program brings together a board-certified medical dermatologist who specializes in psoriasis and a pharmacist from Yale New Haven Hospital Ambulatory Clinical Pharmacy Services who is an expert in psoriasis medication management and coordinating insurance coverage. Together, this dedicated team can manage patients’ care in a seamless fashion, which ensures prompt care. One medical professional focuses on the disease process and treatment selection; the other medication management. In this collaborative model, patients meet with their physician first to discuss a treatment plan and talk separately with the pharmacist. The pharmacist talks in depth with the patient, obtaining a complete medical history and answering all questions related to potential laboratory tests and prescribed medications, which can include injections they self-administer at home, as well as oral and topical treatments. The two points of access mean that patients aren’t condensing all of their questions about their treatment plan into one appointment, and the two medical professionals communicate closely about their psoriasis patients. If one is not available to help, the other can. Patients can work directly with their pharmacist on all issues related to medications, side effects, and insurance coverage in between follow-up appointments with their physician. Having two points of contact allows patients timely access to their medical team as well as their prescribed medications. The program brings together a physician who has expertise in treating psoriasis and a pharmacist with additional training in outpatient care and in dermatologic medications, including those for psoriasis. Managing medications for dermatologic patients is the pharmacist’s full-time job. The pharmacist educates patients about the medications and can obtain insurance coverage and set up home delivery of the medications, taking many hassles and obstacles out of the patient’s hands.

Our program, focused on adult primary care, is known for its excellence and emphasis on prevention and wellness. We efficiently manage potential medical problems as they arise, and collaborate with specialists when needed. Our practice includes internal medicine physicians, advanced nurse practitioners, a clinical psychologist, a social worker, registered-nurse patient care coordinators, licensed practical nurses, medical assistants, clerical office staff, and a practice supervisor. Our goal is to provide patients with the highest quality, personalized healthcare in the Patient-Centered Medical Home (PCMH) model of care. The PCMH model of care focuses on five areas: Building strong, collaborative health care teams that work together to meet the needs of patients Providing patient-centered care addressing the whole person, respecting patients’ values and preferences Coordinating comprehensive health care through clear communication among patients, families, caregivers, medical and behavioral health providers, hospitals, and other facilities Improving patients’ access to care, through such initiatives as expanded office hours and providing email access to electronic medical records Improving health care quality and standards by providing evidence-based care, patient and family education, and self-management support We would like to hear your direct feedback regarding your experience as a patient/family member of our clinic. Please visit the YIMA Patient/Family Comment Box to provide your feedback. Sign up for MyChart , our secure online patient portal, that gives you access to all of your Yale health information whenever you need it, wherever you may be.